FDA Issues OTC “Time & Extent” Application Draft Guidance
This article was originally published in The Tan Sheet
Executive Summary
Time and extent applications for OTC monograph eligibility should describe adverse event reporting systems in countries outside the U.S. where active ingredients have been marketed, according to an FDA draft guidance